Speed of bacterial kill with a fluoroquinolone compared with nonfluoroquinolones: Clinical implications and a review of kinetics of kill studies

Advances in Therapy

Volumn 24, Issue 5, 2007, Pages 1098-1112

  Lichtenstein, Steven J ^a   Wagner, Rudolph S ^b   Jamison, Tiffany ^c   Bell, Belinda ^c   Stroman, David W ^c  

^a UNIVERSITY OF ILLINOIS   (United States)

^b INSTITUTE OF OPHTHALMOLOGY AND VISUAL SCIENCE   (United States)

^c ALCON RESEARCH LTD   (United States)

Author keywords

Antibiotic; Azithromycin; Conjunctivitis; Fluoroquinolone; Gentamicin; Moxifloxacin; Polymyxin B trimethoprim; Tobramycin

Indexed keywords

AZASITE; AZITHROMYCIN; GENTAMICIN; MOXIFLOXACIN; POLYTRIM; TOBRAMYCIN; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GROWTH; BACTERIAL KINETICS; BACTERICIDAL ACTIVITY; BACTERIUM COLONY; CLINICAL TRIAL; CONJUNCTIVITIS; DISEASE COURSE; DISEASE DURATION; DISEASE TRANSMISSION; HAEMOPHILUS INFLUENZAE TYPE A; HUMAN; MINIMUM INHIBITORY CONCENTRATION; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIA;

EID: 37249074385     PISSN: 0741238X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02877716     Document Type: Article

References (17)

1. Lichtenstein SJ, Dorman M, Kennedy R, Stroman D. Controlling contagious bacterial conjunctivitis. J Pediatr Ophthalmol Strabismus. 2006;43:19-26.
2. Martin M, Turco JH, Zegans ME, et al. An outbreak of conjunctivitis due to atypical Streptococcus pneumoniae. N Engl J Med. 2003;348:1112-1121.
3. Bodor FF. Diagnosis and management of acute conjunctivitis. Semin Infect Dis. 1998;9:27-30.
4. Weiss A, Brinser JH, Nazar-Stewart V. Acute conjunctivitis in childhood. J Pediatr. 1993;122:10-14.
5. Isenberg SJ, Apt L, Valenton M, et al. A controlled trial of povidone-iodine to treat infectious conjunctivitis in children. Am J Ophthalmol. 2002;134:681-688.
6. Stroman DW, Cupp GA, Schlech BA. Resistance patterns in conjunctivitis and blepharitis in 2006. Invest Ophthalmol Vis Sci. 2007;48. ARVO E-Abstract 2680.
7. Chalita MR, Höfling-Lima AL, Paranhos A Jr, Schor P, Belfort R Jr. Shifting trends in in vitro antibiotic susceptibilities for common ocular isolates during a period of 15 years. Am J Ophthalmol. 2004;137:43-51.
8. Mah FS. New antibiotics for bacterial infections. Ophthalmol Clin North Am. 2003;16:11-27.
9. Hwang DG. Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. Surv Ophthalmol. 2004;49(suppl 2):S79-S83.
10. Kowalski RP, Yates KA, Romanowski EG, Karenchak LM, Mah FS, Gordon YJ. An ophthalmologist's guide to understanding antibiotic susceptibility and minimum inhibitory concentration data. Ophthalmology. 2005;112:1987-1991.
11. Malhotra-Kumar S, Lammens C, Coenen S, Van Herck K, Goossens H. Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet. 2007;369:482-490.
12. Ohnsman C, Ritterband D, O'Brien T, Girgis D, Kabat A. Comparison of azithromycin and moxifloxacin against bacterial isolates causing conjunctivitis. Curr Med Res Opin. 2007;23:2241-2249.
13. Ohnsman CM. Exclusion of students with conjunctivitis from school: policies of state departments of health. J Pediatr Ophthalmol Strabismus. 2007;44:101-105.
14. Stroman DW, Dajcs JJ, Cupp GA, Schlech BA. In vitro and in vivo potency of moxifloxacin and moxifloxacin ophthalmic solution 0.5%, a new topical fluoroquinolone. Surv Ophthalmol. 2005;50(suppl 1):S16-S31.
15. Wagner RS, Abelson MB, Shapiro A, Torkildsen G. Evaluation of moxifloxacin, ciprofloxacin, gatifloxacin, ofloxacin, and levofloxacin concentrations in human conjunctival tissue. Arch Ophthalmol. 2005;123:1282-1283.
16. Owen GR, Brooks AC, James O, Robertson SM. A novel in vivo rabbit model that mimics human dosing to determine the distribution of antibiotics in ocular tissues. J Ocul Pharmacol Ther. 2007;23:335-342.
17. Friedlaender MH, Protzko E. Clinical development of 1% azithromycin in DuraSite®, a topical azalide antiinfective for ocular surface therapy. Clin Ophthalmol. 2007;1:3-10.